Pathophysiology

The pathological process of oral mucositis starts in the cell (DNA, the cell wall, etc.) when chemotherapy and/or radiation is started.11

  • The pathogenesis of mucositis is not entirely understood, but involves direct and indirect mechanisms. The direct effects, caused by irradiation and chemotherapy, cause lesions of the oral epithelium by interfering with cell renewal and by causing apoptosis. The indirect effects lead to oral mucositis through the release of inflammatory mediators, the loss of protective salivary components and neutropenia induced by the treatment. These factors increase the likelihood of the emergence of bacterial, viral and fungal infections on the damaged mucosa.5

Pathophysiology diagram

Stage 1: Initialization
This stage corresponds to the lesions directly caused by the irradiation or the chemotherapy which adversely affects the cells and the strands of DNA in the basal epithelium and the submucosa. Free radicals (Reactive Oxygen Species or ROS) are also generated and play a mediating role in the biological events of the later stages (direct damage to the mucosa and indirect damage by activating transcription factors).

Stage 2: Primary response to the adverse effect on the cells and the DNA
The adverse effect on the cells and the DNA, and also the ROS, activates a cascade of reactions which bring about the production of pro-inflammatory cytokines. These compounds stimulate a number of pathways leading to lesions or the death of basal cells by apoptosis.

Stage 3: Amplification of the signal
The release of pro-inflammatory cytokines not only damages the cells, but also provides a positive feed-back which amplifies the lesions caused directly by the radiation or the chemotherapy. During this stage the tissue appears to be relatively healthy, with only minor erythemas.

Stage 4: Ulceration
This stage is characterized by painful lesions, subject to colonization by bacteria. This bacterial proliferation will cause new tissue damage and activate the production and release of additional pro-inflammatory cytokines by the infiltrating mononuclear cells.

Stage 5: Healing
Mucositis is generally an acute event that disappears gradually after the cancer treatment has stopped.

After the scarring stage the mucosa appears normal, but residual neo-vascularization persists. It is therefore more fragile and vulnerable to cytotoxic attack and is therefore at a higher risk of severe mucositis in the event of future courses of chemotherapy and/or radiation theraphy.13

EUSAPharma Caphosol
® Caphosol is a registered trademark of EUSA Pharma.